49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 946 / 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05162586 (ClinicalTrials.gov)	December 17, 2021	8/12/2021	A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study t ...	A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study t ...	Systemic Lupus Erythematosus	Drug: M5049 low dose;Drug: M5049 medium dose;Drug: M5049 high dose;Drug: Placebo	EMD Serono Research & Development Institute, Inc.	Merck KGaA, Darmstadt, Germany	Not yet recruiting	18 Years	75 Years	All	440	Phase 2	United States;Germany
2	NCT04647708 (ClinicalTrials.gov)	December 16, 2020	23/11/2020	Study of M5049 in CLE and SLE Participants	A Phase Ib, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety and Pharmacoki ...	Systemic Lupus Erythematosus;Cutaneous Lupus Erythematosus	Drug: M5049;Drug: Placebo	Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany	NULL	Recruiting	18 Years	65 Years	All	44	Phase 1	Bulgaria;Germany;Moldova, Republic of;Spain;Ukraine

First Previous1Next Last